Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes.

Literature DB >> 31959644

Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes.

Kenneth Cusi^1,2.

Abstract

Entities: Disease Species

Mesh：

Year: 2020 PMID： 31959644 DOI： 10.2337/dci19-0064

Source DB: PubMed Journal: Diabetes Care ISSN： 0149-5992 Impact factor: 19.112

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

Review 1. When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD.

Authors: Alba Rojano-Toimil; Jesús Rivera-Esteban; Ramiro Manzano-Nuñez; Juan Bañares; David Martinez Selva; Pablo Gabriel-Medina; Roser Ferrer; Juan M Pericàs; Andreea Ciudin
Journal: J Clin Med Date: 2022-06-08 Impact factor: 4.964

2. Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease.

Authors: Diana Barb; Enrico M Repetto; Michael E Stokes; Sudha S Shankar; Kenneth Cusi
Journal: Obesity (Silver Spring) Date: 2021-09-23 Impact factor: 9.298

3. Nonalcoholic steatohepatitis medical patient journey from the perspective of hepatologists, gastroenterologists and patients: a cross-sectional survey.

Authors: Mary Rinella; Donna R Cryer; Amy Articolo; Travis Fisher; Jennifer Schneider; Karl Nadolsky
Journal: BMC Gastroenterol Date: 2022-07-10 Impact factor: 2.847

Review 4. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.

Authors: Amélio F Godoy-Matos; Wellington S Silva Júnior; Cynthia M Valerio
Journal: Diabetol Metab Syndr Date: 2020-07-14 Impact factor: 3.320

5. Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes.

Authors: Jeff Y Yang; Andrew M Moon; Hannah Kim; Virginia Pate; A Sidney Barritt; Matthew J Crowley; John B Buse; Til Stürmer; Anastasia-Stefania Alexopoulos
Journal: J Diabetes Complications Date: 2020-08-05 Impact factor: 2.852

Review 6. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.

Authors: Fasiha Kanwal; Jay H Shubrook; Leon A Adams; Kim Pfotenhauer; Vincent Wai-Sun Wong; Eugene Wright; Manal F Abdelmalek; Stephen A Harrison; Rohit Loomba; Christos S Mantzoros; Elisabetta Bugianesi; Robert H Eckel; Lee M Kaplan; Hashem B El-Serag; Kenneth Cusi
Journal: Gastroenterology Date: 2021-09-20 Impact factor: 33.883

7. Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD).

Authors: Stergios A Polyzos; Christos S Mantzoros
Journal: Metabolism Date: 2020-07-21 Impact factor: 8.694